Pharmaceuticals Hong Kong

Hong Kong Cannabis Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Hong Kong Cannabis Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Demographic, By Behaviour, By Geography, By Medical vs. Recreational Use) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Hong Kong · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $62.2 Mn Placeholder estimate
Estimate 2025 $71.2 Mn 0.2% of the global market
Projected 2034 $240.8 Mn 238.3% Adds $169.6 Mn over 9 forecast years
CAGR 2025–2034 14.5% Faster than 72% of 180 Pharmaceuticals markets here
Key players 3
  • Hong Kong is 0.16% of the global market.
  • In APAC, the largest is China at $3.60 Bn.
  • Fastest growing: India at 16.5% a year.
  • Hong Kong ranks 6th of 9 by size in APAC.

Market size projection

Hong Kong

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$169.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Cannabis Market market size by year, Hong Kong
YearMarket sizeChange that yearSince 2025
2024 (estimate) $62.2 Mn — —
2025 (base) $71.2 Mn +$9.0 Mn —
2026 (forecast) $81.5 Mn +$10.3 Mn +14.5%
2027 (forecast) $93.3 Mn +$11.8 Mn +31.1%
2028 (forecast) $106.9 Mn +$13.5 Mn +50.1%
2029 (forecast) $122.4 Mn +$15.5 Mn +71.9%
2030 (forecast) $140.1 Mn +$17.7 Mn +96.8%
2031 (forecast) $160.4 Mn +$20.3 Mn +125.3%
2032 (forecast) $183.7 Mn +$23.3 Mn +158%
2033 (forecast) $210.3 Mn +$26.6 Mn +195.4%
2034 (forecast) $240.8 Mn +$30.5 Mn +238.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Hong Kong Cannabis Market Analysis at a glance
Market size, 2025$71.2 Mn placeholder estimate
Forecast, 2034$240.8 Mn placeholder estimate
Growth (CAGR), 2025–203414.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDemographic and behaviour (see all)
Key playersCuraleaf Holdings, Inc., BYND Cannasoft Enterprises Inc., Rodedawg International Industries, Inc. (see all)
Regulator in Hong KongDrug OfficeSource: Drug Office, Department of Health. Checked 14 Nov 2026.
Active clinical trials3 in Hong KongSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 9 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Hong Kong Cannabis Market Analysis Executive Summary

Cannabis is a generalized term that encompasses different preparations obtained from the cannabis plant or Cannabis sativa. It has been found that the chemical responsible for the psychoactivity of cannabis is ∆-9 tetrahydrocannabinol. Cannabinoids are chemical entities that are closely related in structure to THC. Furthermore, other compounds studied in recent years that are not classified as cannabinoids, yet produce akin pharmacological actions. The term ‘marijuana’ which came from Mexico, is generally understood as cannabis leaves, or other plant material in its crude form. Hashish is actually the female plants which are not used in pollination and cannabis oil which is also known as hashish oil is an concentrate of cannabinoids prepared by dissolution in solvents of the marijuana plant or its resin.

With the expansion of cannabis products for legal recreation and medicinal use in several parts of the country, the market has grown rapidly. It is driven by the increase in research on the health benefits of cannabis especially for chronic pain and for mental condition. D-8 Due to the increasing demand for its products among customers, the industry is gradually diversifying its products beyond liquids to topical and edible products. Engagement of investment in the industry is catalyzing product improvement and new product development. Such trends towards legalization all over the world are opening up new markets and economic opportunities. As the knowledge of the medicinal value of cannabis continues to spread, special markets such as the medicinal cannabis market in particular will expand with a possibility for biomedical and pharmaceutical companies.

Bar chart: Hong Kong Cannabis market size, 2024–2034, placeholder estimates. $62.2 Mn in 2024, $71.2 Mn in 2025 and $240.8 Mn in 2034, 14.5% CAGR.
Hong Kong Cannabis market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Hong Kong Cannabis Market Dynamics

Market Growth Drivers

The cannabis market is rapidly expanding due to the progressive legalization of both medicinal and recreational use in various regions. Growing research into the therapeutic benefits of cannabis is driving demand, particularly for treating conditions such as anxiety and chronic pain. Changing perceptions and reduced stigma are enhancing consumer interest, while product diversity, including edibles and topicals, caters to broader preferences. Increased investment is fostering innovation in product development and quality. With global legalization trends, new markets and business opportunities are emerging, and the rise of wellness products like CBD is expected to further stimulate growth. Stricter regulations are improving safety and market credibility, and international trade is likely to expand as legalization advances.

Opportunity

The medicinal cannabis sector is set for growth due to increasing research into its therapeutic benefits for conditions such as anxiety and chronic pain, presenting opportunities for pharmaceutical and biomedical companies. The market is expanding with new products like edibles and beverages, while additional services such as packaging and compliance are emerging. Cross-sector partnerships, especially with biotechnology, can enhance market reach and help navigate regulatory challenges. Growing consumer demand for ethically and sustainably produced cannabis products is creating opportunities for businesses that prioritize social responsibility.

Market Restraints

The cannabis industry encounters challenges despite legalization efforts, including complex and varying laws across regions that complicate market entry and operations. In the U.S., federal legislative obstacles can impede growth and investment. Market saturation in developed areas like Canada and certain U.S. states has resulted in price competition and diminished profit margins. The ongoing black market provides cheaper, unregulated alternatives, hindering the legal market’s expansion. Economic factors such as inflation and shifting consumer spending can affect sales, while the COVID-19 pandemic has intensified supply chain issues, leading to potential shortages and increased costs.

Competitive Landscape for Cannabis Market in Hong Kong

Key Players

Recent Developments:

April 2024, Germany has legalized possession of small amounts of cannabis.

Feb 2024, Heavy cannabis use linked to increased risk of developing a new anxiety disorder

Mergers and Acquisitions

February 2025, TPCO Holding Corp announced an all-stock merger with Gold Flora, a significant move in the California market and notable for being entirely conducted with marijuana stocks.

June 2025, Canadian company TerrAscend Corp revealed two acquisitions in the newly legalized Maryland market, totalling just under $30 million- small deals in the broader M&A landscape.

August 2025, Planet 13 Holdings disclosed its acquisition of Florida-based VidaCann LLC, marking its entry into Florida's growing market. The deal, valued just under $50 million, is modest by M&A standards.

Healthcare Policies and Regulatory Landscape for Cannabis Market in Hong Kong

Cannabis in Hong Kong: rules, payment and research

Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health.⁠[1] Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.⁠[2] ClinicalTrials.gov lists 3 studies on Cannabis that are recruiting, active or about to start in Hong Kong.⁠[3]

[1] Drug Office, Department of Health. Checked 14 Nov 2026.

[2] Hospital Authority. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 9 Nov 2026.

Policy changes and Reimbursement scenario

The U.S. Department of Health and Human Services (HHS) has recommended reclassifying cannabis from Schedule I to Schedule III, potentially paving the way for nationwide medical marijuana use and partial legalization. Over 58% of Americans now reside in areas where cannabis is legal for recreational or therapeutic purposes. As of February 2024, 38 states and three territories have legalized cannabis in some capacity, reflecting increasing acceptance. Federal rescheduling could influence government spending on programs like Medicare and Medicaid, possibly raising healthcare costs while enhancing patient access. Legalization could also elevate state tax revenues, as demonstrated in states like Colorado and Washington, although the illegal market and potential offsets may diminish expected federal tax income.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Cannabis right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Cannabis in context

Hong Kong compared

  • People aged 65 and over: 23.7% of people (2025). World: 10.4% of people (2025). 2nd highest of the 16 countries we cover in APAC.[1]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Cannabis market in Hong Kong?
Placeholder estimate: about $71.2 Mn in 2025, rising to about $240.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Cannabis market in Hong Kong growing?
Placeholder estimate: about 14.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Cannabis market report cover?
The report splits the market by demographic (Age and Gender, Income Levels) and behaviour (Usage Rate, Loyalty Status).
Who are the key players in the Cannabis market?
Key players include Curaleaf Holdings, Inc., BYND Cannasoft Enterprises Inc. and Rodedawg International Industries, Inc..
What is driving the Cannabis market?
The cannabis market is rapidly expanding due to the progressive legalization of both medicinal and recreational use in various regions. Growing research into the therapeutic benefits of cannabis is driving demand, particularly for treating conditions such as anxiety and chronic pain.
Who regulates Cannabis in Hong Kong?
Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health. Source: Drug Office, Department of Health. Checked 14 Nov 2026.
How is healthcare paid for in Hong Kong?
Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government. Source: Hospital Authority. Checked 14 Nov 2026.
How many clinical trials on Cannabis are running in Hong Kong?
3 studies are recruiting, active or about to start in Hong Kong, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 9 Nov 2026.
How much research is published on Cannabis?
PubMed lists 11,235 papers on Cannabis added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Hong Kong

See all

Related on cannabis and cbd

See the topic